What does the published scientific research say about Bacillus laterosporus?

Eight PubMed articles index Bacillus laterosporus, also classified as Brevibacillus laterosporus, in a plant-input context, covering plant growth promotion, biocontrol activity, and antimicrobial properties.

Peer-reviewed research reports that strain K75, isolated from maize rhizosphere, significantly improved root and shoot weight, leaf weight, chlorophyll content, and specific leaf area in maize under both sterile and unsterilized soil conditions. Genome analysis linked these effects to genes for indole-3-acetic acid production and phosphate solubilization, cited in the literature as promising traits for inoculant formulation.

The literature documents Brevibacillus laterosporus as an entomopathogen and broad-spectrum antimicrobial, reported against insect pests across Lepidoptera, Diptera, and Coleoptera, as well as phytopathogenic bacteria and fungi. One study confirmed endophytic colonization of Brassica crops, with a significant reduction in diamondback moth pupation on inoculated plants. Biosynthetic gene clusters for polyketides, non-ribosomal peptides, and bacteriocins appear across multiple sequenced strains.

One indexed publication describes a rare human osteomyelitis case attributed to B. laterosporus in an immunocompetent patient, characterized as opportunistic. Researchers studying Bacillus laterosporus safety profiles for agricultural use should weigh this clinical data point alongside the species' biocontrol literature.